{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Search results for "ORPHAN DRUG" in comments (approximate match)
Status:
Investigational
Source:
NCT00090493: Phase 2/Phase 3 Interventional Completed Multiple Myeloma
(2004)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT04262479: Phase 2 Interventional Completed Latent Autoimmune Diabetes in Adults
(2020)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT02279498: Phase 3 Interventional Completed Exocrine Pancreatic Insufficiency
(2015)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT01081691: Phase 1 Interventional Completed Healthy
(2010)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT04295538: Phase 2 Interventional Active, not recruiting Spinal Cord Injury (SCI)
(2020)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT00003478: Phase 1/Phase 2 Interventional Completed Brain and Central Nervous System Tumors
(1997)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT01777243: Phase 1 Interventional Completed Amyloidosis
(2013)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT02279498: Phase 3 Interventional Completed Exocrine Pancreatic Insufficiency
(2015)
Source URL:
Class:
PROTEIN
Status:
Investigational
Class:
PROTEIN
Status:
Investigational
Source:
INN:adegramotide [INN]
Source URL:
Class:
PROTEIN
